Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryokichi Koyama

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Biochemical Pharmacology|June 17, 2017
Rho kinase-dependent desensitization of GPR39; a unique mechanism of GPCR downregulationYuji Shimizu, Ryokichi Koyama, Tomohiro Kawamoto
Molecular Pharmacology|February 6, 2021
Chronic Exposure to SCO-267, an Allosteric GPR40 Full Agonist, Is Effective in Improving Glycemic Control in RatsRyokichi Koyama, Mitsugi Ookawara, Masanori Watanabe, et al.
Biochemical and Biophysical Research Communications|August 6, 2018
Discovery of artificial VIPR2-antagonist peptides possessing receptor- and ligand-selectivityKotaro Sakamoto, Ryokichi Koyama, Yusuke Kamada, et al.
The Prostate|April 12, 2017
Glycogen synthase kinase-3 inhibitors suppress the AR-V7-mediated transcription and selectively inhibit cell growth in AR-V7-positive prostate cancer cellsDaisuke Nakata, Ryokichi Koyama, Kazuhide Nakayama, et al.
European Journal of Endocrinology|May 7, 2026
First Clinical Demonstration of Sustained IGF-1 Elevation via Oral SSTR5 Antagonism: A Phase 1 Trial of SCO-240Harunobu Nishizaki, Jun Sugama, Hideki Hirose, et al.
Nature Communications|August 12, 2021
The enzymatic activity of inositol hexakisphosphate kinase controls circulating phosphate in mammalsYusuke Moritoh, Shin-Ichi Abe, Hiroki Akiyama, et al.
Biochemical and Biophysical Research Communications|January 1, 2017
Novel DOCK2-selective inhibitory peptide that suppresses B-cell line migrationKotaro Sakamoto, Yusuke Adachi, Yusaku Komoike, et al.
Assay and Drug Development Technologies|June 7, 2018
Cholesterol Unbound RORγt Protein Enables a Sensitive Inverse Agonist ScreeningRyokichi Koyama, Yasunori Fukuda, Yusuke Kamada, et al.
Biochemical and Biophysical Research Communications|October 24, 2009
A novel l-isoleucine hydroxylating enzyme, l-isoleucine dioxygenase from Bacillus thuringiensis, produces (2S,3R,4S)-4-hydroxyisoleucineTomohiro Kodera, Sergey V Smirnov, Natalya N Samsonova, et al.
Journal of Medicinal Chemistry|June 9, 2017
Development of Protein Degradation Inducers of Androgen Receptor by Conjugation of Androgen Receptor Ligands and Inhibitor of Apoptosis Protein LigandsNorihito Shibata, Katsunori Nagai, Yoko Morita, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Biochemical Pharmacology|June 17, 2017
Rho kinase-dependent desensitization of GPR39; a unique mechanism of GPCR downregulationYuji Shimizu, Ryokichi Koyama, Tomohiro Kawamoto
Molecular Pharmacology|February 6, 2021
Chronic Exposure to SCO-267, an Allosteric GPR40 Full Agonist, Is Effective in Improving Glycemic Control in RatsRyokichi Koyama, Mitsugi Ookawara, Masanori Watanabe, et al.
Biochemical and Biophysical Research Communications|August 6, 2018
Discovery of artificial VIPR2-antagonist peptides possessing receptor- and ligand-selectivityKotaro Sakamoto, Ryokichi Koyama, Yusuke Kamada, et al.
The Prostate|April 12, 2017
Glycogen synthase kinase-3 inhibitors suppress the AR-V7-mediated transcription and selectively inhibit cell growth in AR-V7-positive prostate cancer cellsDaisuke Nakata, Ryokichi Koyama, Kazuhide Nakayama, et al.
European Journal of Endocrinology|May 7, 2026
First Clinical Demonstration of Sustained IGF-1 Elevation via Oral SSTR5 Antagonism: A Phase 1 Trial of SCO-240Harunobu Nishizaki, Jun Sugama, Hideki Hirose, et al.
Nature Communications|August 12, 2021
The enzymatic activity of inositol hexakisphosphate kinase controls circulating phosphate in mammalsYusuke Moritoh, Shin-Ichi Abe, Hiroki Akiyama, et al.
Biochemical and Biophysical Research Communications|January 1, 2017
Novel DOCK2-selective inhibitory peptide that suppresses B-cell line migrationKotaro Sakamoto, Yusuke Adachi, Yusaku Komoike, et al.
Assay and Drug Development Technologies|June 7, 2018
Cholesterol Unbound RORγt Protein Enables a Sensitive Inverse Agonist ScreeningRyokichi Koyama, Yasunori Fukuda, Yusuke Kamada, et al.
Biochemical and Biophysical Research Communications|October 24, 2009
A novel l-isoleucine hydroxylating enzyme, l-isoleucine dioxygenase from Bacillus thuringiensis, produces (2S,3R,4S)-4-hydroxyisoleucineTomohiro Kodera, Sergey V Smirnov, Natalya N Samsonova, et al.
Journal of Medicinal Chemistry|June 9, 2017
Development of Protein Degradation Inducers of Androgen Receptor by Conjugation of Androgen Receptor Ligands and Inhibitor of Apoptosis Protein LigandsNorihito Shibata, Katsunori Nagai, Yoko Morita, et al.
Pageof 2